Investing in the Future of Precision Cancer Medicine

Developing a first-in-class, 3rd generation Polo-like Kinase 1 (PLK1) Inhibitor to treat leukemias, lymphomas
and solid tumor cancers

7th Annual LD Micro Invitational Conference
 June 7, 2017
 11:30am - 12:00pm PDT

Trovagene CEO, Bill Welch, will be presenting at the 7th Annual LD Micro Invitational Conference June 7, 2017 at 11:30 AM PDT at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.  The presentation will be webcast live at http://wsw.com/website/ldmicro12/trov and can also be accessed through the Trovagene website at www.trovagene.investorroom.com.  A replay of the presentation will be available and archived for 90 days.